Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method to treat migraines using CGRP antibodies

Method to treat migraines using CGRP antibodies

US Patent 9505838 · Granted Nov 29, 2016

Estimated economic value: $388,821,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-human CD19 antibodies2023
DNA molecules encoding anti-IL-33 antibodies2021
Anti-CGRP/anti-IL-23 bispecific antibodies and uses thereof2020
Anti-IL-33 antibodies and uses thereof for disease treatment2019
Anti-CD20− / anti-BAFF bispecific antibodies2018
Anti-BAFF-anti-IL-17 bispecific antibodies2017
Anti-BAFF-anti-IL-17 bispecific antibodies2017
Fibroblast growth factor 21 variant, composition , and uses thereof2016
Anti-TNF-anti-IL-17 bispecific antibodies2016
Anti-BAFF-anti-IL-17 bispecific antibodies2016
Anti-BAFF-anti-IL-17 bispecific antibodies2016
Multifunctional antibodies binding to EGFR and MET2016